VolitionRX Ltd. (VNRX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1162588,
    "name": "VolitionRX Ltd.",
    "stock_name": "VolitionRX Ltd.",
    "full_name": "VolitionRX Ltd.",
    "name_url": "stocks-analysis/volitionrx",
    "exchange": 215,
    "exchangecode": "ASE",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.31",
    "chg": 0.03,
    "chgp": "9.49%",
    "dir": 1,
    "prev_price": "0.28",
    "mcapval": "65.74",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US9286611077",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "4.79 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/volitionrx-1162588-215&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is VolitionRX Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-volitionrx-ltd-technically-bullish-or-bearish-3547318",
        "imagepath": "",
        "date": "2025-09-20 19:52:40",
        "description": "As of 12 September 2025, the technical trend for VolitionRX Ltd. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and KST are mildly bearish, creating a mixed signal overall. The monthly MACD and KST, however, are mildly bullish, suggesting some positive momentum over a longer timeframe. The Bollinger Bands and Dow Theory indicate bearish conditions on the weekly and monthly charts, which adds to the uncertainty.\n\nIn terms of performance, VolitionRX has underperformed compared to the S&P 500 across multiple periods, with a 1-year return of 1.61% versus 17.14% for the S&P 500, and a significant decline of 79.93% over the past 5 years compared to a 96.61% gain in the index. Overall, the current technical stance is mildly bullish, but the mixed indicators suggest caution...."
      },
      {
        "title": "Is VolitionRX Ltd. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-volitionrx-ltd-overvalued-or-undervalued-3543717",
        "imagepath": "",
        "date": "2025-09-20 18:26:45",
        "description": "As of 14 November 2024, the valuation grade for VolitionRX Ltd. has moved from does not qualify to risky, indicating a significant deterioration in its investment profile. The company appears to be overvalued, given its negative valuation ratios, including a Price to Book Value of -2.06 and an EV to EBITDA of -2.67, which suggest that the market is pricing the stock unfavorably compared to its fundamental value. Additionally, the EV to Sales ratio stands at 46.73, further highlighting the company's overvaluation relative to its revenue generation.\n\nIn comparison to its peers, VolitionRX Ltd. has a less favorable EV to EBITDA ratio than Perspective Therapeutics, Inc. at -0.7951 and Prenetics Global Ltd. at -1.5438, both of which also fall into the risky category. Notably, VolitionRX has underperformed against the S&P 500, with a 3-year return of -62.40% compared to the index's 70.41%, reinforcing the notion ..."
      }
    ],
    "total": 7,
    "sid": "1162588",
    "stock_news_url": "https://www.marketsmojo.com/news/volitionrx-1162588"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is VolitionRX Ltd. technically bullish or bearish?

2025-09-20 19:52:40

As of 12 September 2025, the technical trend for VolitionRX Ltd. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and KST are mildly bearish, creating a mixed signal overall. The monthly MACD and KST, however, are mildly bullish, suggesting some positive momentum over a longer timeframe. The Bollinger Bands and Dow Theory indicate bearish conditions on the weekly and monthly charts, which adds to the uncertainty. In terms of performance, VolitionRX has underperformed compared to the S&P 500 across multiple periods, with a 1-year return of 1.61% versus 17.14% for the S&P 500, and a significant decline of 79.93% over the past 5 years compared to a 96.61% gain in the index. Overall, the current technical stance is mildly bullish, but the mixed indicators suggest caution....

Is VolitionRX Ltd. overvalued or undervalued?

2025-09-20 18:26:45

As of 14 November 2024, the valuation grade for VolitionRX Ltd. has moved from does not qualify to risky, indicating a significant deterioration in its investment profile. The company appears to be overvalued, given its negative valuation ratios, including a Price to Book Value of -2.06 and an EV to EBITDA of -2.67, which suggest that the market is pricing the stock unfavorably compared to its fundamental value. Additionally, the EV to Sales ratio stands at 46.73, further highlighting the company's overvaluation relative to its revenue generation. In comparison to its peers, VolitionRX Ltd. has a less favorable EV to EBITDA ratio than Perspective Therapeutics, Inc. at -0.7951 and Prenetics Global Ltd. at -1.5438, both of which also fall into the risky category. Notably, VolitionRX has underperformed against the S&P 500, with a 3-year return of -62.40% compared to the index's 70.41%, reinforcing the notion ...

View All News